The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays.

We have characterized autoantibodies to nuclear and nucleolar antigens in 112 patients with diffuse scleroderma, CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias), scleroderma overlap syndromes, or primary Raynaud's phenomenon by indirect immunofluorescence and radiolabeled immunoprecipitation assays. We noted for the first time that anti-Th RNP antibodies represent a common antibody specificity in scleroderma (occurring in 13% of patients with scleroderma-like illnesses) and that anti-NOR 90 antibodies are quite rare in American patients (none found). In addition, we describe 3 new scleroderma-associated autoantibodies.

[1]  J. N. Topper,et al.  The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P. , 1989, Science.

[2]  F. Arnett,et al.  Antibodies against Ku protein in sera from patients with autoimmune diseases. , 1989, Clinical and experimental immunology.

[3]  S. Altman,et al.  Antibodies in human serum that precipitate ribonuclease P. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Mimori,et al.  The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. , 1988, The Journal of clinical investigation.

[5]  G. Reimer,et al.  Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus. , 1988, Experimental cell research.

[6]  G. Reimer,et al.  Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). , 1988, Arthritis and rheumatism.

[7]  W. Earnshaw,et al.  Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. , 1988, Arthritis and rheumatism.

[8]  T. Medsger,et al.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.

[9]  J. Rodríguez-Sánchez,et al.  Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. , 1987, Journal of immunology.

[10]  J. Steitz,et al.  Structural analysis of the human U3 ribonucleoprotein particle reveal a conserved sequence available for base pairing with pre-rRNA. , 1987, Molecular and cellular biology.

[11]  G. Reimer,et al.  Autoantibody to RNA polymerase I in scleroderma sera. , 1987, The Journal of clinical investigation.

[12]  G. Reimer,et al.  Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. , 1986, Journal of immunology.

[13]  W. Earnshaw,et al.  High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. , 1986, Science.

[14]  W. Earnshaw,et al.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. , 1986, The Journal of clinical investigation.

[15]  T. Medsger,et al.  Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. , 1984, Arthritis and rheumatism.

[16]  J. Rice,et al.  Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants. , 1983, Arthritis and rheumatism.

[17]  J. Steitz,et al.  Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. , 1982, The Journal of clinical investigation.

[18]  E. Tan,et al.  Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. , 1982, Clinical and experimental immunology.

[19]  T. Mimori,et al.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. , 1981, The Journal of clinical investigation.

[20]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[21]  M. Fritzler,et al.  The CREST syndrome: a distinct serologic entity with anticentromere antibodies. , 1980, The American journal of medicine.

[22]  E. Tan,et al.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. , 1980, Arthritis and rheumatism.

[23]  E. Tan,et al.  Autoantibody to centromere (kinetochore) in scleroderma sera. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Steitz,et al.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Masi,et al.  Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.

[26]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.